Health Discovery Inks Second Biomarker, Pathway Deal with MD Anderson Cancer Center | GenomeWeb

NEW YORK, Jan. 26 (GenomeWeb News) - Health Discovery said today that it has signed an agreement acquiring the first option to obtain the exclusive worldwide rights to commercialize prostate cancer biomarkers or pathways identified by the company as part of a collaboration with the University of Texas, MD Anderson Cancer Center.


Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: gene flow between ancient chimpanzees and bonobos, and more.

A startup wants to match customers to wine based on their DNA and one critic calls the idea 'silly,' Stat News reports.

Researchers trace the origins of brown rats using genetic analysis to China, the New York Times reports.

In Nature this week: genetic history of HIV in the US, and more.